Prothena Co. plc (NASDAQ:PRTA) Given Average Rating of Moderate Buy by Analysts

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target price among brokers […]

Related Keywords

China ,United States ,Brandons Smith ,Hideki Garren ,Nasdaq ,Nisa Investment Advisors ,Prothena Corporation ,Prothena Company Profile ,Lazard Asset Management ,China Universal Asset Management Co ,Tower Group ,Cantor Fitzgerald ,Prothena Co ,Securities Exchange Commission ,Get Free Report ,Exchange Commission ,Universal Asset Management ,Investment Advisors ,Asset Management ,Stock Down ,Get Free ,Prothena Daily ,Prothena ,Nasdaq Prta ,Pprta ,Medical ,Ratings ,Consensus ,